Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine

Public

Shared by NobleBlocks on Oct 1, 2007 • 12:00 AM UTC

Authors:

Jiangtao Lin

Jiansan Zhang

Nan Su

Abstract

The inactivated vaccine was safe and well tolerated and can elicit SARS-CoV-specific neutralizing antibodies.

Finding related papers...

(0)

No comments yet

Be the first to share your thoughts!